[Federal Register Volume 89, Number 246 (Monday, December 23, 2024)]
[Notices]
[Pages 104553-104554]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30555]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Aging; Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial

[[Page 104554]]

property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Institute on Aging Special Emphasis 
Panel; Alzheimer's Disease Drug Development Program.
    Date: January 23, 2025.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institute on Aging, 5601 Fishers Lane, Suite 
8B, Rockville, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Mariel Jais, PharmD, Scientific Review Officer, 
National Institute of Aging, National Institute of Health, 5601 
Fishers Lane, Room 2E400, Rockville, MD 20852, (301) 594-2614, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging 
Research, National Institutes of Health, HHS)

    Dated: December 17, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-30555 Filed 12-20-24; 8:45 am]
BILLING CODE 4140-01-P